Avadel Pharmaceuticals plc

Q2 2025 13F Holders

Symbol
AVDL
CUSIP
G29687103
Type
Equity
Class
COM SHS
Num filings
182
Total reported value, excl. options
$720 M
Manager Report Date Value ($000) Shares Option Type